SCHEMBL5488065

SCHEMBL5488065

COc1ccc(-c2cccc([C@H]3CCN(C(=O)OC(C)(C)C)CC3OCc3ccc4ccccc4c3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.44
MERTK Q12866 1/20 0.44
BACE1 P56817 2/20 0.42
BACE2 Q9Y5Z0 1/20 0.42
GPR119 Q8TDV5 1/20 0.42
REN P00797 1/20 0.42
KDM4E B2RXH2 3/20 0.41
USP30 Q70CQ3 3/20 0.41
HTT P42858 2/20 0.41
YAP1 P46937 2/20 0.40
PRMT5 O14744 1/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
TGFBR1 P36897 1/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
CRHBP P24387 1/20 0.40
KMT2A Q03164 1/20 0.40
CRHR2 Q13324 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812012 1.00 AXL (0.44) AXLMERTKBACE1BACE2GPR119
SCHEMBL2812015 1.00 AXL (0.44) AXLMERTKBACE1BACE2GPR119
SCHEMBL2807737 0.94 BACE1 (0.45) BACE1BACE2RENUSP30YAP1
SCHEMBL2807739 0.94 BACE1 (0.45) BACE1BACE2RENUSP30YAP1
SCHEMBL2809385 0.91 TACR1 (0.41) BACE1BACE2RENUSP30YAP1
SCHEMBL2809383 0.91 TACR1 (0.41) BACE1BACE2RENUSP30YAP1
SCHEMBL2814916 0.89 USP30 (0.43) AXLMERTKBACE1BACE2GPR119
SCHEMBL2810600 0.89 REN (0.43) AXLMERTKBACE1BACE2GPR119
SCHEMBL2814919 0.89 USP30 (0.43) AXLMERTKBACE1BACE2GPR119
SCHEMBL2810602 0.89 REN (0.43) AXLMERTKBACE1BACE2GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070078164-A1 4-Phenylpiperidine derivatives as renin inhibitors SEDRANI RICHARD 2007-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078164-A1 4-Phenylpiperidine derivatives as renin inhibitors REN, AGTR1, ACE AXL 3632/4885MERTK 3307/4885BACE1 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.